HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chong Luo Selected Research

Osteosarcoma (Osteogenic Sarcoma)

1/2018CEACAM6 is associated with osteosarcoma metastasis and facilitates epithelial-mesenchymal transition in osteosarcoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chong Luo Research Topics

Disease

3Juvenile Arthritis (Juvenile Idiopathic Arthritis)
02/2023 - 12/2019
3Pain (Aches)
10/2019 - 01/2017
3Autosomal Dominant Polycystic Kidney (ADPKD)
01/2019 - 11/2015
2Neoplasms (Cancer)
01/2021 - 01/2018
2Endotoxemia
01/2012 - 01/2011
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2023
1Osteoarthritis
01/2023
1Myositis (Idiopathic Inflammatory Myopathies)
04/2022
1Dermatomyositis (Dermatopolymyositis)
04/2022
1Infections
04/2022
1Skin Ulcer
04/2022
1Arthritis (Polyarthritis)
01/2021
1Fever (Fevers)
01/2021
1Lymphoma (Lymphomas)
01/2021
1Postoperative Pain
08/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
01/2018
1Scoliosis
05/2017
1Constipation
01/2017
1Lordosis
01/2017
1Chronic Pain
01/2017
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
02/2016
1Ciliopathies
11/2015
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2015
1Hyperoxia
02/2013
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2011
1Inflammation (Inflammations)
01/2011
1Lymphatic Metastasis
11/2010

Drug/Important Bio-Agent (IBA)

2Membrane Proteins (Integral Membrane Proteins)IBA
01/2019 - 11/2015
2TRPP Cation ChannelsIBA
01/2018 - 02/2016
2LipopolysaccharidesIBA
01/2012 - 01/2011
1belimumabIBA
08/2023
1LigandsIBA
02/2023
1pelargonidinIBA
01/2023
1AutoantibodiesIBA
04/2022
1nuclear matrix protein 2IBA
04/2022
1Nuclear Matrix-Associated ProteinsIBA
04/2022
1tocilizumab (atlizumab)FDA Link
01/2021
1AntigensIBA
01/2021
1Chimeric Antigen ReceptorsIBA
01/2021
125-hydroxyvitamin DIBA
12/2019
1Vitamin DFDA LinkGeneric
12/2019
1SteroidsIBA
10/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1Transient Receptor Potential ChannelsIBA
01/2018
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2018
1Carcinoembryonic AntigenIBA
01/2018
1Cell Adhesion MoleculesIBA
01/2018
1Opioid Analgesics (Opioids)IBA
01/2017
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2017
1TapentadolFDA Link
01/2017
1Naloxone (Narcan)FDA LinkGeneric
01/2017
1CationsIBA
02/2016
1Pentylenetetrazole (Metrazol)IBA
02/2016
1CollagenIBA
01/2015
1Sirolimus (Rapamycin)FDA Link
01/2015
1ParaquatIBA
01/2015
1HydrogenIBA
02/2013
1Oxygen (Dioxygen)IBA
02/2013
1AntioxidantsIBA
02/2013
1CytokinesIBA
01/2011
1NucleolinIBA
11/2010
1EndostatinsIBA
11/2010

Therapy/Procedure

3Therapeutics
01/2021 - 01/2015
1Injections
10/2019
1Braces
05/2017
1Diskectomy (Discectomy)
01/2017
1Laminectomy
01/2017
1Laminoplasty
01/2017
1Analgesia
01/2017
1Intraperitoneal Injections
01/2012